Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency.

MLA

Yoshitomo Hoshino, et al. “Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency.” Journal of Clinical Endocrinology & Metabolism, vol. 109, no. 3, Mar. 2024, pp. e983–96. EBSCOhost, https://doi.org/10.1210/clinem/dgad694.

APA

Yoshitomo Hoshino, Kosuke Inoue, Sara Ikeda, Yukiko Goshima, Keita Tatsushima, Noriaki Fukuhara, Mitsuo Okada, Hiroshi Nishioka, Shozo Yamada, Yasuhiro Takeuchi, & Akira Takeshita. (2024). Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency. Journal of Clinical Endocrinology & Metabolism, 109(3), e983–e996. https://doi.org/10.1210/clinem/dgad694

Chicago

Yoshitomo Hoshino, Kosuke Inoue, Sara Ikeda, Yukiko Goshima, Keita Tatsushima, Noriaki Fukuhara, Mitsuo Okada, et al. 2024. “Clinical Factors Affecting Daily Dosage of Desmopressin Orally Disintegrating Tablets in Arginine Vasopressin Deficiency.” Journal of Clinical Endocrinology & Metabolism 109 (3): e983–96. doi:10.1210/clinem/dgad694.